CVE-2017-12714
Abbott Laboratories pacemakers manufactured prior to Aug 28, 2017 do not restrict or limit the number of correctly formatted "RF wake-up" commands that can be received, which may allow a nearby attacker to repeatedly send commands to reduce pacemaker…
Does this matter?
Lower severity and a low EPSS score (0.65%). Track it; it rarely justifies an emergency change on its own.
Description
Abbott Laboratories pacemakers manufactured prior to Aug 28, 2017 do not restrict or limit the number of correctly formatted "RF wake-up" commands that can be received, which may allow a nearby attacker to repeatedly send commands to reduce pacemaker battery life. CVSS v3 base score: 5.3, CVSS vector string: AV:A/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:H. Abbott has developed a firmware update to help mitigate the identified vulnerabilities.
- CVSS 3.0
- 6.5 MEDIUMCVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
- EPSS
- 0.65% probability · 49th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-920
- Affected
- abbott/accent firmware · abbott/anthem firmware · abbott/accent mri firmware · abbott/accent st firmware · abbott/assurity firmware · abbott/allure firmware · abbott/assurity mri firmware
- Source
- ics-cert@hq.dhs.gov
References
- http://www.securityfocus.com/bid/100523Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-17-241-01Third Party Advisory, US Government Resource
- http://www.securityfocus.com/bid/100523Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-17-241-01Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.